Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) EBT Margin (2017 - 2025)

Catheter Precision has reported EBT Margin over the past 9 years, most recently at 2547.06% for Q4 2025.

  • Quarterly EBT Margin fell 87793.0% to 2547.06% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2381.56% through Dec 2025, up 83320.0% year-over-year, with the annual reading at 2381.56% for FY2025, 83320.0% up from the prior year.
  • EBT Margin was 2547.06% for Q4 2025 at Catheter Precision, down from 1002.65% in the prior quarter.
  • Over five years, EBT Margin peaked at 522.29% in Q2 2021 and troughed at 171925.0% in Q1 2021.
  • The 5-year median for EBT Margin is 3298.58% (2024), against an average of 45615.65%.
  • Year-over-year, EBT Margin tumbled -17136452bps in 2021 and then skyrocketed 16731833bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 165660.0% in 2021, then decreased by -2bps to 168960.0% in 2022, then skyrocketed by 100bps to 522.66% in 2023, then crashed by -219bps to 1669.13% in 2024, then tumbled by -53bps to 2547.06% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's EBT Margin are 2547.06% (Q4 2025), 1002.65% (Q3 2025), and 3022.64% (Q2 2025).